Findings

What do systematic reviews say?

4 questions · 4 findings · 3 reviews · Hepato-Biliary

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 50%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 50%Moderate 0 · 0%High 0 · 0%

Microwave coagulation in addition to conventional transarterial chemoembolisation vs chemoembolisation

Time to mortality · people with liver metastases

The review found no eligible studies for this question.

1 finding from 1 review

Microwave coagulation for liver metastases 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Microwave coagulation in addition to conventional transarterial chemoembolisation vs chemoembolisation

All‐cause mortality · people with liver metastases

The review found no eligible studies for this question.

1 finding from 1 review

Microwave coagulation for liver metastases 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

External beam radiotherapy (EBRT) plus transarterial chemoembolisation (TACE) vs TACE alone

Mortality Number of deaths at maximum · participants with unresectable hepatocellular carcinoma

External beam radiotherapy (EBRT) plus transarterial… may leads to lower all‐cause mortality (at maximum 1‐year compared with TACE alone (low certainty).

1 finding from 1 review

External beam radiotherapy for unresectable hepatocellular carcinoma 2017 · Cochrane Headline outcomes only
RR 0.51 [0.41, 0.62]
9 studies · 786 participants
Low

TACE followed by 3‐DCRT vs chemoembolisation

All‐cause mortality: at 3 years · primary hepatocellular carcinoma

TACE followed by 3‐DCRT may leads to lower all‐cause mortality: at 3 years compared with TACE (low certainty).

1 finding from 1 review

Transcatheter arterial chemoembolisation followed by three‐dimensional conformal radiotherapy versus transcatheter… 2019 · Cochrane Headline outcomes only
RR 0.8 [0.73, 0.88]
7 studies · 552 participants
Low